Analyst Price Target is $14.00
▲ +54.53% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.00, with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 54.53% upside from the last price of $9.06.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Aurinia Pharmaceuticals. This Buy consensus rating has held steady for over two years.